News

Kotsopoulos J, Apostol AI, Metcalfe K, Jorgji D, Cybulski C, Gronwald J, Lubinski J, Moller P, Kim RH, Aeilts A, Ramón Y Cajal T, Pal T, Bordeleau L, Karlan BY, Singer CF, Foulkes WD, Couch FJ, Zakalik D, Fruscio R, Tung N, Sun P, Monteiro AN, Narod SA, Akbari MR, Hereditary Breast Cancer Clinical Study Group (2025)
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1
Curr Oncol, 32 (12)
DOI 10.3390/curroncol32120705, PubMed 41440233

Bope CD, Kalyanasundaram S, Rand KD, Nakken S, Lingjærde OC, Hovig E (2025)
StarSignDNA: mutation-to-signature attribution for accurate representation of mutational processes in low-mutation contexts
NAR Genom Bioinform, 7 (4), lqaf181
DOI 10.1093/nargab/lqaf181, PubMed 41415301

Kotsopoulos J, Seca M, Gronwald J, Huzarski T, Møller P, Kim RH, Singer CF, Karlan B, Aeilts A, Ramón Y Cajal T, Pal T, Eisen A, Bordeleau L, Foulkes WD, Tung N, Couch F, Neuhausen SL, Zakalik D, Cybulski C, Olopade O, Metcalfe K, Fruscio R, Sun P, Lubinski J, Narod SA (2025)
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2
J Natl Cancer Inst (in press)
DOI 10.1093/jnci/djaf363, PubMed 41403285